Literature DB >> 2841997

Fluconazole in the treatment of candidal prosthetic valve endocarditis.

B J Isalska1, T N Stanbridge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2841997      PMCID： PMC1834227          DOI： 10.1136/bmj.297.6642.178

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Tissue penetration of amphotericin B in Candida endocarditis.

Authors:  E Rubinstein; E R Noriega; M S Simberkoff; J J Rahal
Journal:  Chest       Date:  1974-10       Impact factor: 9.410

2.  Patterns of Candida endocarditis following cardiac surgery: Importance of early diagnosis and therapy (an analysis of 91 cases).

Authors:  M S Seelig; C P Speth; P J Kozinn; C L Taschdjian; E F Toni; P Goldberg
Journal:  Prog Cardiovasc Dis       Date:  1974 Sep-Oct       Impact factor: 8.194

3.  Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro.

Authors:  F C Odds; S L Cheesman; A B Abbott
Journal:  J Antimicrob Chemother       Date:  1986-10       Impact factor: 5.790

4.  Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo.

Authors:  T E Rogers; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

5.  Fungal endocarditis: analysis of 24 cases and review of the literature.

Authors:  E Rubinstein; E R Noriega; M S Simberkoff; R Holzman; J J Rahal
Journal:  Medicine (Baltimore)       Date:  1975-07       Impact factor: 1.889
  5 in total
  13 in total

1.  Failure of fluconazole in systemic candidiasis.

Authors:  Y Siegman-Igra; M Y Rabaw
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

Review 2.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

3.  Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.

Authors:  D Debruyne
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

4.  Fluconazole therapy of candidal native valve endocarditis.

Authors:  E Roupie; J Y Darmon; L Brochard; M Saada; N Rekik; C Brun-Buisson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-05       Impact factor: 3.267

5.  Fluconazole and phenytoin: a predictable interaction.

Authors:  A S Mitchell; J T Holland
Journal:  BMJ       Date:  1989-05-13

Review 6.  Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses.

Authors:  S M Grant; S P Clissold
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

7.  Fluconazole treatment of candidal infections caused by non-albicans Candida species.

Authors:  J W van 't Wout
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-03       Impact factor: 3.267

Review 8.  Fungal endocarditis--a report on seven cases and a brief review.

Authors:  H Hogevik; K Alestig
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

Review 9.  Candida parapsilosis endocarditis: a comparative review of the literature.

Authors:  C Garzoni; V A Nobre; J Garbino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12       Impact factor: 3.267

10.  The efficacy of fluconazole in treating prosthetic valve endocarditis caused by Candida glabrata: report of a case.

Authors:  T Nishida; H Mayumi; Y Kawachi; S Tokunaga; Y Maruyama; A Nakashima; H Yasui; K Tokunaga
Journal:  Surg Today       Date:  1994       Impact factor: 2.549
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.